U · A
Unknown Author
January 24, 2026
Latham Advises Octopus Ventures and Redalpine Capital on ExpressionEdits’ £10.2 Million Series Seed Financing
1 min
AI-made summary
- Latham & Watkins advised Octopus Ventures and Redalpine Capital as lead investors in the £10.2 million Series Seed funding round for ExpressionEdits, a biotechnology company focused on optimizing protein expression through AI and proprietary intronization technology
- The funding round was led by Octopus Ventures and Redalpine, with additional participation from BlueYard Capital, Wilbe Capital, Acequia Capital, Amino Collective, and Hawktail
- The Latham team was led by partner Shing Lo.
Latham & Watkins has advised Octopus Ventures and Redalpine Capital as lead investors on the £10.2 million Series Seed funding round of ExpressionEdits, a biotechnology company optimizing protein expression using AI and proprietary intronization technology. The round was led by Octopus Ventures and Redalpine, with participation from BlueYard Capital, Wilbe Capital, Acequia Capital, Amino Collective, and Hawktail. The Latham team was led by London corporate partner Shing Lo, with associates Samantha Peacock and Venice Ma.~~
U
Article Author
Unknown Author
The Sponsor
